TP53 mutations in circulating tumor DNA for response monitoring in patients with high grade serous carcinoma of ovary

被引：0
|
作者：
Kim, Y. M. [1 ]
Lee, S. W. [1 ]
Lee, H. Y. [2 ]
Lee, S. E. [2 ]
Park, Y. R. [3 ]
Kim, J. H. [1 ]
Kim, Y. T. [1 ]
Nam, J. H. [1 ]
机构：
[1] Univ Ulsan, Coll Med, ASAN Med Ctr, Seoul, South Korea
[2] Asan Inst Life Sci, Seoul, South Korea
[3] Asan Med Ctr, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：12 / 13
页数：3
相关论文
共 50 条
  • [21] Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
    Tuna, Musaffe
    Ju, Zhenlin
    Yoshihara, Kosuke
    Amos, Christopher I.
    Tanyi, Janos L.
    Mills, Gordon B.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (03) : 405 - 412
  • [22] TP53 mutations as a biomarker for high-grade serous ovarian cancer: are we there yet?
    Oien, Derek B.
    Chien, Jeremy
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S264 - S268
  • [23] Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
    Musaffe Tuna
    Zhenlin Ju
    Kosuke Yoshihara
    Christopher I. Amos
    Janos L. Tanyi
    Gordon B. Mills
    [J]. British Journal of Cancer, 2020, 122 : 405 - 412
  • [24] TP53 mutations in circulating tumor DNA associate with klebsiella pneumoniae inbreast cancer
    Hou, Ming-Feng
    Chiang, Chih-Po
    Chang, Chuan-Hsin
    Lien, Wei-Ting
    Yang, Ming-Je
    Yeh, Yao-Tsung
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [25] TP53 mutations on circulating cell-free DNA
    Pantel, Klaus
    [J]. EBIOMEDICINE, 2016, 10 : 15 - +
  • [26] Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma
    Krimmel-Morrison, Jeffrey D.
    Ghezelayagh, Talayeh S.
    Lian, Shenyi
    Zhang, Yuezheng
    Fredrickson, Jeanne
    Nachmanson, Daniela
    Baker, Kathryn T.
    Radke, Marc R.
    Hun, Enna
    Norquist, Barbara M.
    Emond, Mary J.
    Swisher, Elizabeth M.
    Risques, Rosa Ana
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 156 (02) : 407 - 414
  • [27] Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas
    Kfoury, Maria
    Bonnet, Clement
    Delanoy, Nicolas
    Howarth, Karen
    Marzac, Christophe
    Rouleau, Etienne
    Micol, Jean-Baptiste
    Leary, Alexandra
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [28] Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients
    Long, Xiaolu
    Gu, Jia
    Lou, Yaoyao
    Xu, Qian
    Cai, Haodong
    Zhang, Wei
    Shen, Kefeng
    Xiao, Min
    Zhang, Yicheng
    Chen, Liting
    Zhou, Jianfeng
    [J]. BLOOD, 2018, 132
  • [29] Immunohistochemistry predicts presence and type of TP53 mutation in high-grade serous carcinoma
    Koebel, Martin
    Piskorz, Anna
    Liu, Shuhong
    Brenton, James D.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [30] Most High Grade Serous Carcinomas Arising in Low Grade Serous Carcinomas Do Not Show Evidence of TP53 or BRAF Mutations
    Zarei, Shabnam
    Kerr, Sarah E.
    Wang, Yan
    Jenkins, Sarah M.
    Bell, Debra A.
    [J]. MODERN PATHOLOGY, 2016, 29 : 315A - 315A
12345